Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Microdebrider in nose-throat surgeries]
2011	HAYES, Inc.	Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in children
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Combination therapy for pulmonary arterial hypertension: a review of the clinical effectiveness
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Exercise therapy (Krankengymnastik / Heilgymnastik) in physical medicine]
2011	Institute for Clinical and Economic Review (ICER)	Management options for low back disorders
2011	Committee for New Health Technology Assessment (CNHTA)	[Non-invasive cardiac output monitoring by bioreactance technology]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[The coblation technique in tonsillectomy]
2011	HAYES, Inc.	Mobile cardiac outpatient telemetry (MCOT) (CardioNet ambulatory ECG monitor; CardioNet Inc.) for home monitoring of cardiac patients
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Celecoxib versus non-COX-2 selective non-steroidal anti-inflammatory drugs: a review of the clinical effectiveness, safety, and cost effectiveness
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Informative value of Patient-Reported Outcomes (PRO) in Health Technology Assessment (HTA)]
2011	Committee for New Health Technology Assessment (CNHTA)	[Enterovirus real-time rt-pcr]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Ipilimumab for pre-treated patients with advanced/metastatic melanoma
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dabigatran and rivaroxaban as thrombophylaxis after major orthopedic surgery]
2011	HAYES, Inc.	Office-based phototherapy for treatment of atopic dermatitis in adults
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Celecoxib versus non-selective non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical effectiveness, safety, and cost-effectiveness
2011	Committee for New Health Technology Assessment (CNHTA)	[Urine neural thread protein test]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Nilotinib (Tasigna) for the 1st-line treatment of Philadelphia chromosome positive chronic myeloid leukemia in the chronic phase
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Rational use of self-monitoring of blood glucose in type 1 diabetes]
2011	HAYES, Inc.	Office-based phototherapy for treatment of atopic dermatitis in children
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Eliglustat tartrate, miglustat, imiglucerase, velaglucerase or a combination of these for the treatment of Gaucher disease: a review of clinical effectiveness and safety
2011	Committee for New Health Technology Assessment (CNHTA)	[Deletion of 18q choromosome in colorectal cancer (LOH, loss of heterozygosity)]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Cabazitaxel (Jevtana) for the second-line therapy of patients with hormone-refractory metastatic prostate cancer
2011	HAYES, Inc.	OptiVol fluid status monitoring system (Medtronic Inc.) for management of heart failure
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011	Committee for New Health Technology Assessment (CNHTA)	[Photodynamic therapy for bladder, cervix and lung cancer]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Annual Report 2010. German version.]
2011	HAYES, Inc.	Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	[Surgical stabilization of a flail chest wall]
2011	Committee for New Health Technology Assessment (CNHTA)	[C-11-acetate positron emission tomography, positron emission tomography/computed tomography]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Annual Report 2010. English version
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Functional Electric Stimulation (FES) for children with cerebral palsy: clinical effectiveness
2011	HAYES, Inc.	Provenge (Dendreon Corp.) vaccine for treatment of prostate cancer
2011	The Regional Health Technology Assessment Centre (HTA-centrum)	[Active mobilization after flexor tendon repairs in zone II of the hand]
2011	Committee for New Health Technology Assessment (CNHTA)	[Intraoperative Radiotherapy with Low Energy X-rays]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness
2011	HAYES, Inc.	Relieva balloon sinuplasty (Acclarent Inc.) for treatment of chronic sinusitis
2011	NIHR Horizon Scanning Centre (NIHR HSC)	IRay™ for wet age related macular degeneration
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in esophageal cancer
2011	Committee for New Health Technology Assessment (CNHTA)	[Microvolt T-wave alternans system]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Dasatinib (Sprycel) for the first-line therapy of patients with newly diagnosed chronic phase philadelphia chromosome positive chronic myeloid leukemia.
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Umbilical cord clamp removal: a review of the clinical benefits and harms
2011	HAYES, Inc.	Sacroiliac joint fusion for treatment of adult low back pain
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	X-ray versus gamma irradiation of blood components for prevention of transfusion-associated graft versus host disease: a brief report
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in colorectal cancer
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Diabetic foot ulcers - a health technology assessment]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-stress testing for pregnant adults with diabetes
2011	HAYES, Inc.	Sensei X robotic catheter system (Hansen Medical Inc.) for treatment of atrial fibrillation
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	The use of Lactobacillus probiotics in the prevention of antibiotic associated clostridium difficile diarrhea
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Surgical dressing for patients undergoing hip or knee arthroplasty: clinical effectiveness and cost-effectiveness
2011	HAYES, Inc.	SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Drug eluting stents. What should be the indications for their use at the MUHC?
2011	National Institute for Health and Care Excellence (NICE)	MiraQ for assessing graft flow during coronary artery bypass graft surgery. NICE medical technologies guidance 8
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Alglucosidase alpha (Myozyme) for treatment of patients with late-onset Pompe disease]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Auditory screening and hearing loss prevention: a review of the clinical evidence and guidelines
2011	HAYES, Inc.	Tandem autologous peripheral blood stem cell transplantation for neuroblastoma
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Subglottic secretion drainage endotracheal tubes for prevention of ventilator-associated pneumonia
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus center]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines
2011	HAYES, Inc.	Ultroid hemorrhoid management system (Ultroid Technologies Inc.)
2011	Basque Office for Health Technology Assessment (OSTEBA)	[Genetics development plan in the Basque Country]
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Brain injury rehabilitation - a health technology assessment]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cardiac output monitors to assess patient resuscitation needs: a review of clinical effectiveness and cost-effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Clopidogrel, Prasugrel and Ticagrelor in adults with acute coronary syndrome: a review of the clinical effectiveness
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Nurse-endoscopy of the colon; a randomized trial on accuracy, patient experiences and costs]
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Antipsychotic polypharmacy in the treatment of schizophrenia]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Quality assessment of the Canadian attention deficit hyperactivity disorder resource alliance ADHD practice guidelines in adults with ADHD
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Multidisciplinary medication review in long term care: a review of the clinical evidence and guidelines
2011	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Aortic valve bypass (apicoaortic conduit) in adult degenerative aortic stenosis
2011	Basque Office for Health Technology Assessment (OSTEBA)	[Financing procedures in primary care adequate for resources and efficiency, by means of adjusted clinical groups (ACG)]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[A prospective, randomised controlled trial comparing in-hospital treatment and early assisted discharge for exacerbations of chronic obstructive pulmonary disease (COPD)]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Miglustat (Zavesca) for patients with type 1 Gaucher's disease]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Comparative effectiveness of rosuvastatin versus other statins: a review of clinical effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Metabolic monitoring and interventions for reducing metabolic syndrome in patients treated with atypical antipsychotics: a review of the clinical evidence
2011	Health Technology and Policy Unit (HTPU)	Middle ear implants for the treatment of hearing loss
2011	Scottish Health Technologies Group (SHTG)	Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults
2011	National Evidence-based Healthcare Collaborating Agency (NECA)	[Effects of glucosamine in patients with osteoarthritis]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Quantifying COPD patients preferences for early assisted discharge and inpatient hospital care for COPD exacerbations: a discrete choice experiment]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Pazopanib (Votrient) for the treatment of patients with advanced renal cell carcinoma]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Facet joint injection as diagnostic and therapeutic tools for pain of the cervical and lumbar spine: a review of clinical and cost-effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bisphosphonates for the prevention of osteoporosis in patients treated with systematic corticosteroids: a review of the clinical evidence and guidelines
2011	Institut national d'excellence en sante et en services sociaux (INESSS)	[Computed tomography and its carcinogenic effects in children and youth in Québec]
2011	Health Technology and Policy Unit (HTPU)	Photodynamic therapy for skin cancer & pre-cancerous skin conditions
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management and patient safety of IVIG administration: a review of clinical practice guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	T-score as a measurement to assess the 10-year fracture risk: a review of the clinical evidence
2011	HTA Unit, University of Calgary	Health technology reassessment and reinvestment: a systematic review of current practices
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Trabectedin (Yondelis) for the treatment of ovarian cancer]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pediatric supraglottic airway devices: a review of clinical effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Adrenal suppression and clinical harms by inhaled corticosteroids: a review of safety and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Robotic surgery versus open-chest surgery for internal mammary artery harvesting and mitral valve surgery: clinical effectiveness
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Acetylsalicylic acid for venous thromboembolism prophylaxis: a review of clinical evidence, benefits and harms
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	In vitro test for the evaluation of individual risk of metastasis in surgically treated women for breast cancer
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Feeding tube verification procedures: optimal timing and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Phallometric assessment of sex offenders: a review of the clinical evidence and guidelines
2011	NIHR Health Technology Assessment programme	Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): two parallel randomised controlled trials
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-adherent versus traditional dressings for wound care: comparative effectiveness, safety, and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone for short-term detoxification: a review of the clinical evidence
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous insulin infusions in labouring women: guidelines